Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Jan;79(2):690–694. doi: 10.1073/pnas.79.2.690

Opioids regulate cGMP formation in cloned neuroblastoma cells

Germaine J Gwynn 1, Erminio Costa 1,*
PMCID: PMC345812  PMID: 16593149

Abstract

Opioid agonists caused a rapid dose-related elevation of the cGMP content of N4TG1 murine neuroblastoma cells. An excellent correlation was found between the rank order of potency of agonists in stimulating cGMP accumulation and in displacing [3H]etorphine ([3H]ETP) bound to intact cells. The narcotic antagonists naloxone and diprenorphine failed to increase cGMP content; moreover, in the presence of 5 μM naloxone, the EC50 of ETP increased from ≈9 nM to > 1 μM. N4TG1 cells that had been incubated for 20 min with 0.32 μM ETP and thoroughly washed displayed a marked loss in sensitivity to subsequent ETP challenge. This desensitization was characterized by a 40-50% decrease in maximal response and an increase in the apparent Ka of ETP from 4 to 50 nM. Desensitization was complete after a 7-min incubation with 0.32 μM ETP (t½ ≈ 1 min) and was only slowly reversible (t½ > 60 min). Naloxone (5 μM) and diprenorphine (0.1 μM) failed to elicit desensitization, but they blocked ETP-induced desensitization. Dextrophan and (+)-ethylketazocine were <1% as effective as levorphanol and (-)-ethylketazocine, respectively, in both stimulating cGMP accumulation and inducing desensitization. When the binding of [3H]ETP (0.2-20 nM) was examined under identical experimental conditions, cells that were completely desensitized by incubation with ETP (7 min with 0.32 μM or 20 min with 15 nM) showed no loss of high-affinity recognition sites. After longer incubation with ETP (0.32 μM for 20-60 min), the maximal binding of [3H]ETP was reduced 17-41%. The specific short-term desensitization of cGMP accumulation is not mediated or accompanied by a decrement in the number of agonist binding sites.

Keywords: cyclic nucleotides, opiate receptor, desensitization

Full text

PDF
690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amano T., Hamprecht B., Kemper W. High activity of choline acetyltransferase induced in neuroblastoma x glia hybrid cells. Exp Cell Res. 1974 Apr;85(2):399–408. doi: 10.1016/0014-4827(74)90142-6. [DOI] [PubMed] [Google Scholar]
  2. Bartfai T., Breakefield X. O., Greengard P. Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cells. Biochem J. 1978 Oct 15;176(1):119–127. doi: 10.1042/bj1760119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Biggio G., Guidotti A., Costa E. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):117–121. doi: 10.1007/BF00508462. [DOI] [PubMed] [Google Scholar]
  4. Brandt M., Buchen C., Hamprecht B. Relationship between the actions of calcium ions, opiods, and prostaglandin E1 on the level of cyclic AMP in neuroblastoma x glioma hybrid cells. J Neurochem. 1980 Mar;34(3):643–651. doi: 10.1111/j.1471-4159.1980.tb11192.x. [DOI] [PubMed] [Google Scholar]
  5. Brandt M., Gullis R. J., Fischer K., Buchen C., Hamprecht B., Moröder L., Wunsch E. Enkephalin regulates the levels of cyclic nucleotides in neuroblastoma x glioma hybrid cells. Nature. 1976 Jul 22;262(5566):311–313. doi: 10.1038/262311a0. [DOI] [PubMed] [Google Scholar]
  6. Breakefield X. O. Neurotransmitter metabolism in murine neuroblastoma cells. Life Sci. 1976 Feb 1;18(3):267–278. doi: 10.1016/0024-3205(76)90055-2. [DOI] [PubMed] [Google Scholar]
  7. Chang K. J., Cuatrecasas P. Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. J Biol Chem. 1979 Apr 25;254(8):2610–2618. [PubMed] [Google Scholar]
  8. Chang K. J., Miller R. J., Cuatrecasas P. Interaction of enkephalin with opiate receptors in intact cultured cells. Mol Pharmacol. 1978 Nov;14(6):961–970. [PubMed] [Google Scholar]
  9. Chapman D. B., Way E. L. Metal ion interactions with opiates. Annu Rev Pharmacol Toxicol. 1980;20:553–579. doi: 10.1146/annurev.pa.20.040180.003005. [DOI] [PubMed] [Google Scholar]
  10. Clouet D. H., O'Callaghan J. P. Role of protein kinases in opiate actions in brain. Adv Biochem Psychopharmacol. 1979;20:281–300. [PubMed] [Google Scholar]
  11. Dawson G., McLawhon R., Miller R. J. Inhibition of sialoglycosphingolipid (ganglioside) biosynthesis in mouse clonal lines N4TG1 and NG108-15 by beta-endorphin, enkephalins, and opiates. J Biol Chem. 1980 Jan 10;255(1):129–137. [PubMed] [Google Scholar]
  12. El-Fakahany E., Richelson E. Involvement of calcium channels in short-term desensitization of muscarinic receptor-mediated cyclic GMP formation in mouse neuroblastoma cells. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6897–6901. doi: 10.1073/pnas.77.11.6897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldberg N. D., Haddox M. K. Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem. 1977;46:823–896. doi: 10.1146/annurev.bi.46.070177.004135. [DOI] [PubMed] [Google Scholar]
  14. Greengard P. Phosphorylated proteins as physiological effectors. Science. 1978 Jan 13;199(4325):146–152. doi: 10.1126/science.22932. [DOI] [PubMed] [Google Scholar]
  15. Gullis R., Traber J., Hamprecht B. Morphine elevates levels of cyclic GMP in a neuroblastoma X glioma hybrid cell line. Nature. 1975 Jul 3;256(5512):57–59. doi: 10.1038/256057a0. [DOI] [PubMed] [Google Scholar]
  16. Hamprecht B., Gullis R. J. Statement. Nature. 1977 Feb 24;265(5596):764–764. doi: 10.1038/265764b0. [DOI] [PubMed] [Google Scholar]
  17. Hamprecht B. Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. Int Rev Cytol. 1977;49:99–170. doi: 10.1016/s0074-7696(08)61948-8. [DOI] [PubMed] [Google Scholar]
  18. Hansson C. G., Karlsson K. A., Samuelsson B. E. The identification of sulphatides in human erythrocyte membrane and their relation to sodium-potassium dependent adenosine triphosphatase. J Biochem. 1978 Mar;83(3):813–819. doi: 10.1093/oxfordjournals.jbchem.a131977. [DOI] [PubMed] [Google Scholar]
  19. Harper J. F., Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [PubMed] [Google Scholar]
  20. Homburger V., Lucas M., Cantau B., Barabe J., Penit J., Bockaert J. Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps. Modification of the coupling and loss of beta-adrenergic receptors. J Biol Chem. 1980 Nov 10;255(21):10436–10444. [PubMed] [Google Scholar]
  21. Klee W. A., Nirenberg M. A neuroblastoma times glioma hybrid cell line with morphine receptors. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3474–3477. doi: 10.1073/pnas.71.9.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klee W. A., Nirenberg M. A neuroblastoma times glioma hybrid cell line with morphine receptors. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3474–3477. doi: 10.1073/pnas.71.9.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Minneman K. P., Iversen I. L. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature. 1976 Jul 22;262(5566):313–314. doi: 10.1038/262313a0. [DOI] [PubMed] [Google Scholar]
  25. O'Callaghan J. P., Chess Q., McKimmey C., Clouet D. H. The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system. J Pharmacol Exp Ther. 1979 Sep;210(3):361–367. [PubMed] [Google Scholar]
  26. Racagni G., Zsilla G., Guidotti A., Costa E. Accumulation of cGMP in striatum of rats injected with narcotic analgesics: antagonism by naltrexone. J Pharm Pharmacol. 1976 Mar;28(3):258–260. doi: 10.1111/j.2042-7158.1976.tb04146.x. [DOI] [PubMed] [Google Scholar]
  27. Rasmussen H., Goodman D. B. Relationships between calcium and cyclic nucleotides in cell activation. Physiol Rev. 1977 Jul;57(3):421–509. doi: 10.1152/physrev.1977.57.3.421. [DOI] [PubMed] [Google Scholar]
  28. Rosenfeld G. C., Strada S. J., Robison G. A. Cyclic nucleotides and the central effects of opiates: an overview of current research. Adv Biochem Psychopharmacol. 1979;20:261–279. [PubMed] [Google Scholar]
  29. Ross D. H., Cardenas H. L. Nerve cell calcium as a messenger for opiate and endorphin actions. Adv Biochem Psychopharmacol. 1979;20:301–336. [PubMed] [Google Scholar]
  30. Sharma S. K., Nirenberg M., Klee W. A. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci U S A. 1975 Feb;72(2):590–594. doi: 10.1073/pnas.72.2.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Study R. E., Breakefield X. O., Bartfai T., Greengard P. Voltage-sensitive calcium channels regulate guanosine 3',5'-cyclic monophosphate levels in neuroblastoma cells. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6295–6299. doi: 10.1073/pnas.75.12.6295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Traber J., Fischer K., Buchen C., Hamprecht B. Muscarinic response to acetylcholine in neuroblastoma times glioma hybrid cells. Nature. 1975 Jun 12;255(5509):558–560. doi: 10.1038/255558a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES